Sormani MP, Häring DA, Kropshofe H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, #277.
Neurodegeneratieve en psychiatrische aandoeningen in ALS-families
jul 2017 | Neuro-musculair